Clinical contraindications to allergen immunotherapy: an EAACI position paper

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|70|8|897-909

ISSN： 0105-4538

Source： ALLERGY, Vol.70, Iss.8, 2015-08, pp. : 897-909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EAACI guidelines on allergen immunotherapy: Prevention of allergy

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 28, Iss. 8, 2017-12 ,pp. : 728-745

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

By  

ALLERGY, Vol. 73, Iss. 1, 2018-01 ,pp. : 64-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper

By  

ALLERGY, Vol. 70, Iss. 7, 2015-07 ,pp. : 755-763

John Wiley & Sons Inc

Access to resources Recommend Favorite

Position paper of the EAACI: food allergy due to immunological cross‐reactions with common inhalant allergens

By  

ALLERGY, Vol. 70, Iss. 9, 2015-09 ,pp. : 1079-1090

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

By  

ALLERGY, Vol. 70, Iss. 6, 2015-06 ,pp. : 707-710

John Wiley & Sons Inc

Access to resources Recommend Favorite